Official Report 494KB pdf
Thank you for inviting me along. I am delighted to be here. As is set out in the paper that I submitted to the committee, I founded the Airlink group at university and I have been involved in international business delegations for some time now. I have set out some points in my submission, which I would be more than happy to discuss further. I will also take any other questions that you may have.
I was introduced to the Estonian market in 2001, when the Baltic states were the hottest opportunity in Europe. Having been out to Estonia, I saw lots of opportunities not only in my sector but in many others.
Good morning, John. The belief that it is good to get as many contacts as possible in other countries is obviously borne out by companies’ increasing interest in exporting. There has been an upturn in that in the past five years, with more and more people doing it. The Parliament has discussed the issue of how best to make contacts. Indeed, the Enterprise and Culture Committee suggested in 2004 and in 2006 that ministerial leadership of trade missions and efforts abroad ought to be much better co-ordinated. However, a 2004 report showed that there had been slightly fewer ministerial visits abroad than in the previous year. You have suggested to us that, when ministers and members of the Scottish Parliament make foreign trips and are accompanied by Scottish companies, they play their part in fighting for Scottish business and give a focus. You have already illustrated that. Do you think that the Government and Parliament can do more to give such leadership at the moment?
Back in 2006, the Enterprise and Culture Committee said in paragraph 150 of its report entitled “Business Growth—the next 10 years”, in a section on enhancing Scotland’s international outreach:
I do not know which one of us members will feel more sorry for.
We will leave that question open.
Perhaps we could put the term “Scotland House” to one side, as it is misleading in some ways. It suggests a bricks-and-mortar presence. We should definitely have a general support mechanism, ideally in every country in the world. According to the United Nations official list, there are 194 countries in the world. Our ambition, which may be deemed an ambitious, blue-sky ambition, should be to have a contact point in every single country.
I should also make the point that although I am currently an ambassador for business club Scotland, that is not my intention in being here today. I accepted that post only because I was involved in the thinking of business club Scotland and how it might evolve. I absolutely believed in the objectives of that organisation prior to being asked to be an ambassador for it. I thought it would be useful to make that clear.
Perhaps I should also declare an interest, in that about 10 years ago I was made a global Scot, on the recommendation of Wendy Alexander. The globalscot network seemed to be a lot livelier in her day, although that perhaps just points to the incestuous nature of Scottish politics.
How many of those advantages would also be found in Lithuania and Latvia? We tend to class all three nations together as the Baltic countries, but I would like to know more about the divergences.
To be honest, I am not familiar with the exact figures, but there seems to be a general rule that larger companies find it much easier to internationalise because they just create a budget, appoint the best people that money can buy and go and make it happen. I am a director of the Entrepreneurial Exchange and our mantra has always been, “Work hard, play hard and give something back.” Our general desire is to take a small company and help it to become a medium-sized company, to help the medium-sized company to become a large company and to help the large company to become a global company and a world leader.
The Scandinavian banks have a good reputation as narrow banks that know their stuff and do not try to become masters of the universe.
It is a bit of both. An SME might hear that doing business abroad can be a good thing, whether that is because it can buy goods and services more cheaply direct from source or because it can sell its products into a foreign market. However, those are daunting tasks, particularly where there are language barriers, which is the case in the majority of countries. To get on a plane, get off at the other end and be on your own and not know anyone is quite a frightening experience the first time you do it. There is a role for an agency to say, “You know what? We as a country believe that this is what we should do. Here’s how we’re going to co-ordinate it, and here’s the support.”
You said that long-term strategic planning is important, and you also make that point in your written submission. Is that the most important thing that the committee could recommend in the report that we will publish at the end of our inquiry?
I return to the menu system that I am proposing. Longevity is the major issue, provided that we have got everything else right. The right product can be in place, but lack of longevity is the thing that deters companies from getting involved. A non-direct-Government body should be charged with doing the work. If BusinessClub Scotland Ltd, for example, was charged with the task, with the globalscot network and the Scotland House model added to the mix, would that be enough? It would not be enough if there was not also forward thinking and longevity. Three years should be the minimum commitment. I am conscious of parliamentary cycles, so there might be some difficulty about the decisions of one Parliament being binding on another, but a three-year rolling commitment would be extremely helpful. Companies might find that there is a trade mission to India or China, but will ask whether it is a one-off event or do business agencies and Government agencies believe that there is a long-term future in those markets. A three-year cycle would help to make people focus and think, “That place has been identified as a key growing market, so we should get involved.” People would know that they would not be left on their own after the first year.
I have a simple question on the Baltic market. We have heard from other witnesses how important Scotland’s educational reputation is in markets such as China and India. In your experience, does that apply in eastern Europe? Do we make as much of it there as we should?
Good morning. I am the site leader for the Dow plastic additives plant in Grangemouth. As you may know, Dow is either the biggest or second-biggest chemical company in the world. Our plant supports our plastics additives business, which is a global exporter from Scotland to not quite 194 countries, but to a significant number of those. Our role is to support that global business.
I am the Scottish adviser to the Chemical Industries Association. The three chemical companies that are represented today are members of the association. I wanted to bring them along so that you could hear directly from them.
I am the general manager of Bio-Rad Laboratories Europe Ltd. We are a manufacturing company in Perth. We manufacture kits for testing newborns. We manufacture about 7 million test kits a year, more than 99 per cent of which are exported.
I support that. INEOS has 17 companies around the globe and we already have our contacts. Our refining products are sold globally. Our European products—including ethylene, propylene, benzene—are sold throughout Europe, and some are sold in America. We have the contacts there, so trade missions are not our number 1 priority.
However, for some of the small and medium-sized enterprises that are just starting out in the chemicals sector, such as small spin-off businesses in the life sciences and biotech, there is value in having mixed trade missions. The chemicals sector supports and underpins a lot of the other manufacturing sectors and is about the biggest exporter, depending on which quarter you look at. The sectors are all interlinked—we serve into automotives, food and drink, the life sciences and a range of different sectors. So, if we are having trade missions for emerging businesses, it is important that they are cross-sectoral missions.
That is a good question. One of my remits is to attract people to Scotland and to the Grangemouth site. I do not have a lot of experience of going around the globe.
That is an important part of it; thank you.
There was an SDI mission to Japan in January, led by Professor Sir Ian Wilmut. For some of our members’ companies to be alongside someone who is the world leader in his field and to be associated with a Scottish university means that, when people come to the meetings, they feel that they are coming to see not only the world’s leading scientist in the field, but the world’s leading companies. It is fantastic to have such a springboard.
I agree that the level of expertise in life sciences and biotech is essential. Most of our members are quite small and cannot be on a plane all the time to visit all the different markets, but we can be on first-name terms with the individuals—for example, Vince is the SDI guy in Japan. When chasing up companies and contacts that need hand holding like that—India is another country in which it will take a lot of work to secure deals—having the expertise and someone who knows not only the company but the science is key.
Prior to a visit to India, SDI gave me a fantastic report on every VIP in Mumbai and New Delhi. It also gave me a list of the people who wanted to see me out there and asked me to tick the boxes. I ticked the boxes thinking that we would get half of them, but everyone said yes, so I was in Mumbai with 14 appointments in one day. SDI laid on a car for me, with a driver who took me around every hospital—I paid for the visit, but it was very well organised and SDI was very helpful.
So there is a combination—SDI brings in the expertise but the basic structure provided by the embassy is important from a logistical point of view.
I will give a lead-in to the answer and Ray Mountford, Peter Hodgson and Andrew Edwards may pick it up. The key thing for us is that in the chemicals sector, the marketplace is very competitive. Some of it is in existing technology, but aspects such as plant efficiency are always developing. The competitiveness element is very important to us, and any advantage that we can get in Scotland makes a huge difference to whether we can retain, develop and attract further investment or whether other locations are chosen over us.
Are you referring to regional selective assistance?
The message from a number of companies is that RSA really makes a difference. However, it is not the simplest of things to operate and there is a bureaucracy associated with it. For a large company, investment decisions often require things to move pretty quickly.
We are trying to sustain our business here in Scotland. The key thing is for us to ensure that the infrastructure here is invested in. It is important to have transport links down the east and west coasts to the container ports. Better still would be to have a better container system out of Scotland. Indeed, 90 per cent of our material is exported, of which about 50 per cent goes to North America. We do not have a direct link from here to North America.
Are you aware of any other European countries or regions where RSA operates in a more bureaucratic or less bureaucratic way? In other words, do you know of anywhere else where these decisions are taken more quickly or where there is flexibility to allow the grant to be processed while other decisions are being made?
I am sure that I will give you the name.
On RSA, which has been dealt with in a number of questions, the Chemical Industries Association’s submission says:
Yes. That question touches on RSA. I know what has happened with Phoenix Chemicals, which is excellent, but we do not want to get into a discussion about who gives the biggest grants and how to secure mobile research and development jobs. Other things will bring companies to Scotland. There are mechanisms other than research and development funding. Smaller and emerging companies benefit greatly from research and development grants and other fiscal mechanisms, but I do not think that things move forward as companies increase in size or are bought and there is a footprint, as we have in Aberdeen with Wyeth and now Pfizer. We must ensure that research and development grants are fit for purpose not just for small companies, but for bigger companies. We are discussing with the Scottish Government how they can be improved, slipstreamed and awarded more quickly. A small company may need more due diligence done on whether it will survive a year or two, but perhaps the bigger companies do not have to go through the same due diligence.
I would like to ask questions about the written submissions. My first question is to the Chemical Industries Association Scotland, whose submission states:
In your final bullet point, you highlight the fact that the quality of life in Scotland is
I do not think that it will have a negative impact on the life science sector, because there is always an influx of the very skilled individuals whom we recruit. Unfortunately, that has to balance the brain drain that is still happening, with people leaving Scotland and the UK. The stance to which you refer is not an issue in our sector, because the best individuals for the job are already in the country, as part of our academic base—they may have studied here—or already working in the industry in the private sector.
My next set of questions is directed to Mr Johnstone. The final sentence of paragraph 5 of your submission states:
With regard to international business angels, there are some key leaders in the business angel field in life science that invest in our early-stage companies. There are Archangel Informal Investment and TRI Cap. Aurora Private Equity, which is in Aberdeen, has dabbled. It is said that if Scotland was looked at globally in the angel sector, it would have the 11th biggest angel investor community in the world, but I would not like to be quoted on that statistic. You would have to ask LINC Scotland about that. Having people such as Nelson Gray, who was last year’s European business angel of the year, going abroad and talking up Scotland as a place to come and invest is a wonderful support. One of the issues arising from not having venture capitalists is that we do not have that investment leadership coming into companies such as NovaBiotics and saying, “We are the cornerstone investment in Scotland and we are leading on this.” If we had that, we would then get other global investors from the United States, Japan and elsewhere coming in to syndicate such a deal. What we are seeing in Scotland is the potential to do that, but with the business angel syndicates. That is a lead that could be taken.
Is that for SDI to sell, or is it for SDI to enable the angel biotech community to sell?
I think SDI should be enabling the angel community because these guys can pretty much go out and do what is required. SDI understands our companies. In the same way, it can understand the mechanics of how the syndicates work in Scotland. SDI should get the angel community out and get them centre stage, as the cornerstone investors.
Is that a Scottish Enterprise matter? Should the public agencies or the Scottish Government support that through the enterprise networks primarily?
Absolutely. The mix of having the local support from Scottish Enterprise, which knows the strengths of the local sectors, and the wider national support that we get from the life science team and so on is key to looking overall at how that super-cluster fits.
Dr O’Neil referred to Scottish Equity Partners, which was originally part of Scottish Enterprise as Scottish development finance. It grew to a position where the guys who led it decided, “This is a good business. We should spin it out.” They spun it out on the basis that they would look after the Scottish community by leading investments and bringing investments in, but that did not happen. A big hole was left because they did not fill the investment space; they were seen as the Scottish venture capitalist, but they did not invest in Scottish companies and nobody else came in. They almost had a monopoly, because they had so much contact with their investments through Scottish Enterprise. I believe that Scottish Enterprise and the Scottish Investment Bank would be wise to have a look at that model, see what worked and think about how they could retain something like that, with the Scottish Investment Bank acting as lead investor.
When I was involved in the management buyout from Axis-Shield in Dundee 12 years ago, the two investors were SEP and 3i; the latter has left Scotland and SEP is putting its money elsewhere. The business angels have been filling the gap left by those two.
I will indicate where I am coming from. As a professor I was a civil servant of the Government of Baden-Württemberg for nearly 30 years and I know the minister who is responsible for research and the universities there. They produce 10,000 technicians a year, compared with the 2,000 in Scotland. Theoretically, their training is funded 50 per cent by the Land and 50 per cent by the industry, although in practical terms it is funded 25 per cent by the Land and 75 per cent by the industry because it trains people up in its own academies, which are funded by Daimler-Benz, Bosch and so on. In comparison, Scotland is at a disadvantage in providing the pool of people that you mentioned.
We might be drifting away from internationalisation, but please feel free to comment.
I was involved in training for many years. The company that I worked for was one of the first to introduce competence-based training and an apprenticeship scheme.
My question is for the big boys. You have talked about infrastructural improvement, which would mean building roads or container terminals, for example, but that is a notoriously ambiguous issue, because if it is easy to take products out, it is also easy to bring them in. We could open ourselves up to even more low-cost competition in that way.
I welcome members to the 14th meeting in 2010 of the Economy, Energy and Tourism Committee. The first of our three agenda items is to continue our inquiry into public sector support for exporters, international trade and the attraction of inward investment. We have two witness panels this morning.
The evidence that we received last week from SDI is that it has not gone down the route of opening more Scotland Houses, because it believes that doing so would not necessarily be the best use of public money. It recognises the need to have a contact in the country, but not necessarily bricks and mortar. Do you accept that approach, or do you think that the Estonia project would suggest otherwise?
Before I ask a question, I should say for the record that John McGlynn and I studied together and that he is a good personal friend of mine.
This is a very sweeping statement but, in my experience, Estonia tends to be more advanced in business and technology thinking than Latvia, which tends to be slightly more advanced than Lithuania. That is just the general trend.
That is linked to the other point that I wanted to ask about. We can be assured that many of those German trade missions would be made up of small and medium-sized enterprises. They are the ball-bearings on which German industry works. Does the non-SME sector in Scotland have the sort of success that it ought to have, proportionate to its level of capitalisation?
Estonia is a sort of east European Hong Kong. Then again, it was, in a sense, a linguistic part of another east European Hong Kong—Finland. Finland had to go through a process of reinvention with the breakup of the Soviet Union. One of the crucial points that I noticed on my trips to Finland was the importance of the Finnish banks—it is some time ago, but they have kept up, there—which operated virtually as a foreign ministry in the days when Finland could not have a foreign policy because of the Kekkonen agreement with Russia. When the present Government took over in Scotland, I surmised that the Scottish banks would play a rather similar role. Spectacularly, they have not done so. Has the malfunctioning of the banking system had any impact on Scotland’s Baltic connections?
Have your operations in the Baltic countries—Estonia in particular—been hit by the difficulties of the banks?
I agree—although we should also consider the Canadian banks, which are one of the best examples of banking that I have found. I have been in Canada quite a lot recently. Canadian banks never gave mortgages of more than two thirds and were conservative in their lending. To a degree, they are saying, “Global crisis? Sorry. What’s happening?” They have not been affected much.
To return to Chris Harvie’s point about SMEs, are the difficulties with internationalisation among SMEs more in the mindset of the businesses than in actual barriers to internationalisation? If so, what can we do about that?
My opinion on all things to do with overheads is that I want fewer of them. I encourage the committee to adopt a maximum-coverage, minimum-overheads approach. At some point in the future, if other activities were to be performed, it may or may not be appropriate to have a physical office presence, but currently it is more important to have good project managers on the ground. Some of those people would probably not cost the Parliament a penny.
I am the global marketing director for Silberline inks products. Silberline is a United Kingdom company that is owned by a US company. We manufacture aluminium pigments, which go into the general coatings industry worldwide, so we export everywhere.
I represent the BioIndustry Association here in Scotland. As Ken Richardson did, we have brought two of our members—Gordon and Debs—along to represent the industry. Throughout the UK, we represent about 300 members ranging from emerging companies and one-man and two-man SMEs to some of the larger players, such as Wyeth, which is now Pfizer, up in Aberdeen.
The bulk of the chemical companies that are based in Scotland are multinationals and the supply chain tends to be fairly well defined in terms of both suppliers and customers. Trade missions are of less use to the larger companies, as they already have international contacts and customers. Ray Mountford may want to pick up on that.
Several different organisations are involved in the trade missions, including SDI, SCDI and UKTI. Are too many bodies involved? Is it too confusing? Does everybody know what is going on, or is there not enough co-ordination? Are you satisfied with the way in which trade missions are organised?
I have not been involved in trade missions; I am passing on what I have been told by a colleague who has been involved. There is sometimes a certain amount of confusion when there is both a Scottish presence and a United Kingdom presence. There is the potential for people who come along from the companies that have manufacturing or research interests in both Scotland and the UK to get a little bit confused. The focus that some of the organisations, including SDI, provide is good and we have had good feedback on that from companies, so I am not knocking what they do; I am just saying that we must be careful. We have had reports that English companies from a manufacturing area that have been present have sometimes been a bit surprised that Scottish companies from that area are present as well.
It is confusing. I have been on a UKTI trade mission this year, and a company with which I am involved has been on an SDI trade mission to Japan. However, for smaller companies, it is great to have the choice and they will use whatever they believe will best promote them. Taking one of those away would be taking away a tool that our members have. We are all global companies—when a company starts in the biotech sector, it is a global company and such trade missions are critical to its survival. Therefore, the more that such companies have to choose from, the better.
I am trying to build up a picture here. It is clearly different for companies that are rooted in Scotland and for international companies such as INEOS. What role do big, international companies, such as INEOS, have in helping to promote Scottish business?
I know the life science sector well because of its significant presence in my constituency. I know the chemicals sector less well, and the balance between existing and new technologies has a different character. How important is it for the life science sector to have a level of expertise in the public agencies with which it works? Does the level of expertise exist and is it readily accessible? As industry leaders and innovators, how far can you complement or feed in directly to that expertise?
It definitely exists, and I can give an example. The head of the Scottish Enterprise life science team, who will be with us next week at the BIO international conference as part of the SDI contingent for our mini mission, has set up meetings that we would not otherwise have been able to have. We can work with her and her team, which is great. The partnership and the expertise, both in Scottish Enterprise and SDI, certainly exist.
So the on-the-ground support exists. Is there also an understanding of the marketplace? For example, NovaBiotics is doing world-leading work, and that must be true for many other Scottish companies in the field. How far can you rely on the public sector to understand what the marketplace is and who you need to meet to maximise the market opportunities in different parts of the world?
It is good and it brings in a high quality of companies.
The chemical industry is clearly in a different place and, I guess, deals more with established technologies and markets. How important are the things that we have heard from the life science companies? For example, how important is an understanding in the public agencies of what the industry sells and does?
The attraction, retention and growth of jobs in Scotland is critical. The industrial base at Grangemouth offers an ideal location for that. We work very closely with our contacts at Scottish Enterprise and SDI, looking at all the possibilities, from someone who wants to come and just use a shed at our facility for blasting and painting structures to someone who wants to bring in green technology—it might be that we have established technology now, but we are always trying to improve it. People bring and develop their plant on our site and look for help in doing so—as everyone does. We have to attract such people here, because plenty of others would like them to go elsewhere.
Yes. If a company makes a commitment before that yes comes through, the bureaucracy will say that there is no point in providing the support, because the company is coming anyway. Also, any amount that is spent before the yes to the grant comes through is not covered. It might only be a small amount for feasibility-type work, but some companies are put off by that, especially by the timing. It is those little things that the committee should be examining.
I echo what Peter Hodgson and Ray Mountford have said. It is the same for us: 90 per cent of our product is exported, the majority of it to Europe, as we have manufacturing sites in Asia and the US. Infrastructure is key. It is a matter of being able to get the product out of the UK cheaply. At the moment, the majority of our material gets shipped down to Hull and put on containers there. Our particular concerns relate to the Forth road crossing and getting material into Europe.
Sometimes the chemical sector hides its light under a bushel, but it accounts for £2.2 billion of exports. The three companies that are represented here are all saying that a significant amount of what they make gets exported. The industry is of major added value to the Scottish and UK economy.
No. We usually rely on our local management for that. In this country, I have to talk with Scottish Enterprise to prepare the groundwork so that we can get assistance easily. When I built plants in China and Mexico, I always felt that people were chasing us a lot more and showing us what we could get instead of our having to ask for it.
I cannot name it, but one of our members, whose headquarters are based in another European country, has found that it gets a lot more leverage there than it can get in Scotland. As I say, though, I cannot give the name of the company in public.
I will speak to you later.
I will make the first attempt at responding, and Peter Hodgson might join in afterwards.
We had exactly the same experience. We had a grant for a certain project that we did not go ahead with. We are now applying for another regional selective assistance grant, but it will take us three months to get the same amount of money and basically the same outcome.
The submission from the BioIndustry Association Scotland is pretty positive about SDI and Scottish Enterprise, but it mentions one area in which there is room for improvement: the retention of companies that are located here. Can Scott Johnstone expand on that point a bit?
That takes us back to the point that I made about many of the companies already being multinational organisations. There is a limited number of potential suppliers of certain products, and economies of scale and location make a difference. Those companies are often already very much aware of whom they can buy from and sell to. Let us take INEOS’s selling as an example. The plastics that are made at its Grangemouth site are not the plastics for end use that you and I would recognise; rather, they take the form of pellets or powder, which a downstream organisation will convert into useful products. The number of such organisations is limited, so the INEOS business team is very much aware of the customers and who it needs to chase. There might be opportunities for new markets from time to time but, generally speaking, companies are pretty much aware of the potential customers.
In paragraph 7 of your written evidence, in answer to question 4 in the committee’s call for evidence, you state that your members
The confusion often occurs not so much between Scotland and the UK, but within the regions in the UK. The Chemical Industries Association, which is the trade association for the industry throughout the UK, seeks to get the regional groupings to work together. The north-east, north-west and Humberside regions, and others, all have a presence.
My next questions are for Dr O’Neil. I want to focus on the final two bullet points in her written submission. The second-last one says that the funding culture in the private sector is
The point goes back in part to Scott Johnstone’s comment about the need to retain companies in Scotland once they reach a certain size, perhaps even beyond the size at which grants are key. It is vital that we can get venture capital or angel money, so it is frustrating that that culture does not seem to exist in Scotland, even though the industry punches above its weight UK-wide. It is the opposite problem from the one that Cambridge has as another centre of excellence in biotech. Organisations in Cambridge find it hard to recruit or retain staff, but easy to raise funds. The situation is completely the opposite for us in that the expertise, the technology and the staff are here, but the VC community does not really play a part. Scottish Equity Partners was one of the last big VC players that we had, but it has now in effect bowed out of life science investments.
The BIA at national level is looking at the issue a great deal. A couple of proposals that we are considering and lobbying for are the R and D tax credit—I am not sure whether you are familiar with that—the patent box and consortium relief, which would allow a larger company to work with a smaller company on a research project and recycle its tax. It is more difficult to implement those changes and to get those powers at national level. For the patent box, we are looking at a level of 10 per cent for the UK, but other countries are considering setting one of 6 per cent, which would immediately put us at a disadvantage. The need for a level playing field across Europe has been highlighted. If Scotland had fiscal power in the area, it could consider the benefit, risk and reward of going for a level of 5 per cent. Making such a change would not be a great loss to the tax pot but would give Scotland a far greater presence globally.
My final question concerns paragraph 6 of your submission, in which you state:
Debs O’Neil pointed out that we had a venture capitalist, which has now left. The business angel community has stepped up to the plate. Like the globalscot network, but locally, it consists of a bunch of individuals who want to help Scotland and are reinvesting in Scotland in exciting sectors such as life science.
Thank you.
May I come back on the issue of finance and the biotech industries? The presentation refers to SDI doing more to promote our business angel community internationally in order to attract similar investment from elsewhere. I would be interested to hear more about that. Dr O’Neil made the point that the spin-outs in Scotland would be better networked strategically rather than simply geographically. Clearly these things go together because innovation and funding must be linked. I would be interested to understand that a little more clearly.
The public sector is likely to have reducing moneys in future years to support international trade and investment. Is it reasonable to ask that relatively established sectors with fairly large companies operating mainly in established markets are left to look after themselves while the public sector concentrates more on emerging markets in Brazil, Russia, India and China—the BRIC countries—and on small and medium-sized enterprises, which may not have the same resources?
It is said that it takes about 10 times as much effort to chase a new customer as to retain an existing one. It is the same with businesses. The chemical sector is of massive value to the Scottish economy. It would be wrong to say, “Leave it to itself.” It can do its own thing on trade and so on in certain areas, but other areas in the sector need support and encouragement, and existing know-how. I have heard companies say that people in the Scottish Enterprise network have been of good value to their organisations and have helped them. RSA works very well in certain areas in ensuring that we remain competitive, because there are areas that could be improved. We want to encourage, support and develop smaller and spin-off companies, and other sectors, but we should not ignore the existing base, because it supports the rest of the economy. That is the message from the chemical sector: We support the rest of the economy. The point is not just the value of our manufacturing exports; it is that other sectors would have difficulty without it.
In the chemical industry, Phoenix Chemicals is a good example of an up and coming company. I know Ian Low of that company very well, so I know that the company is in the process of becoming a member of the BIA. The company has seen the feed-through of some of the earlier-stage work. Many of our companies are small-molecule companies using chemicals that must be manufactured. If we could do that in Scotland, ideally for Scottish use—that is, get them into the NHS, which would be a whole separate inquiry altogether—and have local feed-through, we would attract money and get businesses growing. However, the issue is leveraging larger players such as Pfizer, Phoenix or INEOS to be able to come in and work together—that is what we would look for.
I apologise to Chris Harvie. I did not realise that he wanted to ask a question.
We have operated an apprenticeship scheme for a number of years. It would be easier if we could draw from a pool of people rather than having to make individual decisions about how many people we want. In some years we might want two and in others we might want six, and we have to make that decision four years in advance. It would be better if there was a pool of people—we would be prepared to provide part of the funding—that could supply us with groups of technical people as we need them.
Does INEOS share that view?
INEOS works closely with Falkirk College. We have our own modern apprenticeship scheme with the college. It employs the apprentices, but we fund them. Hopefully, we will find work for those people and they will fill the gap that is beginning to open up in the technician population. Our people are one of our strengths. People come to Scotland because we have the chemicals base, the utilities and the waste treatment, but we also have good, skilful engineers, managers and technicians. The technician population is waning slightly, but our modern apprenticeship scheme with Falkirk College is trying to fill that gap.
How many people do you recruit each year?
For us, the number is between nought and 3. It is difficult to predict because our operation is not as big as INEOS’s.
There were about five questions there. The industry here has already won the battle for low-cost production. My company has. I led a project three years ago that was given as a kind of a mission statement, “Find a way of shutting the plant down at Grangemouth and sourcing it in the rest of the world.” Fortunately, I was unsuccessful and that was mainly because the infrastructure from the refinery supported our plant in Grangemouth. Now, we are going further to develop and optimise our low-cost position, which is why we are looking for infrastructure.
Infrastructure is not only about motorways but about local pipelines and local tankage. We share some of that with Dow. It uses our infrastructure to import some of its material rather than build its own tanks and cause more congestion on the jetties.
Some of the major innovations made in North Sea oil in the 1970s and 1980s came from combining practical experience in the North Sea with theoretical and experimental innovations—for instance, positioning. We were able to do that from Scotland. I wonder how many people around the table even know about that, but it enabled bodies to remain absolutely static in the sea through a combination of satellites, thrusters and computers. That is a combination of the practical and theoretical that was developed offshore. Today, it seems to me to be common for companies to onshore that quality of entrepreneurialism and technical competence.
Your written submission deals quite a bit with the situation in Estonia and the Scotland House issue. Could you expand a bit on your experiences in Estonia, on your conclusions and on any recommendations that you might have for the committee on the way forward for such operations?
What type of support did you get for your project from Scottish Development International and the Scottish Executive? How easy was it to secure that support?
Initially, there was no support whatever. I decided that we would not be critical of any of the agencies, but that we would simply get on and do our own thing as a really good pilot study. Following some meetings with SDI, it was heavily criticised in the press by other parties unconnected to us, who were considering the markets in Latvia and Lithuania more than Tallinn. They were not able to operate from an office in Germany. I gave evidence to the Enterprise and Culture Committee on that during the previous parliamentary session. As I said then, SDI eventually saw that having a contact in the Baltics would be a good thing.
I fully accept the sentiment that bricks and mortar are not needed. We no longer have bricks and mortar in Tallinn, which is fortunate in having lots of amazingly good hotels. When business people travel there, they tend to book a meeting room at one of the hotels or commandeer an area of the lobby, which in effect becomes the office. People stack up meetings there back to back. We spent a lot of money on a bricks-and-mortar office in the old town of Tallinn; that was great for the photographs, but people did not use our services there.
Yes. The most depressing thing for me in the past 12 months, apart from the general credit crunch issues, has been the attack on anyone who dares to travel. That is an outrageous slur on not just politicians, but public servants and people who work in quangos and other organisations, who genuinely want to make a difference. To suggest that someone should go on a one-week trade delegation and not have a night off to go for dinner with colleagues or visit a world-class monument is a disgrace. People do not work 24 hours a day, seven days a week, when they work at home. There seem to be attacks on anyone who travels, and that is very damaging; I have raised that point with newspaper editors. I do not believe that the majority of foreign trips are junkets. There may be one or two that are, out of hundreds.
My experience has not been that there has been resistance. Indeed, anyone in any party to whom I have ever spoken has been very supportive of the idea of foreign trade delegations. It comes back to the machine of government and making things happen. Sometimes it is easier to do business abroad in today’s market, depending on the sector and whether one is exporting or importing. Somebody must be charged with responsibility.
You talked about multisector trade missions. In the written evidence that we have received, some people have argued that multisector trade missions are preferable, but others have suggested that single-sector trade missions are a better approach. I suspect that the answer might be somewhere in between, but why do you say that multisector missions are better? What is the best way forward?
I agree with your comment. In my submission, I stated that I do not suggest that my answer is the only correct one. There is of course a role for single-sector trade missions, but I suggest that that is a niche part of the market. For globalisation and internationalisation, you have to identify companies that have leaders with the right state of mind. It is not about saying that we can take a huge company abroad; it is about considering how to get a small company to internationalise and become a medium-sized company, how to get a medium-sized company to be a large company and how we help large companies to be world class. When there are people with that mindset, I would hate to see a barrier that says, “You are not in one of the chosen few sectors, therefore we have nothing to offer you.”
John McGlynn’s company is headquartered in my constituency and has been a contributor to my constituency Christmas calendar on past occasions. I think that that counts as a declaration of interest, John’s personal political views notwithstanding.
Estonia is uniquely placed in that it straddles both areas very nicely. Culturally and socially, Estonia is absolutely a Scandinavian country; it has more in common with Scandinavia. From a business point of view, Estonia is one of the most advanced countries in the world. It was one of the first countries to abolish cheques. I was surprised by that on my first visit: I was asked why I would want a written piece of paper that needs to be processed and which involves a delay in payment. My reply was that they were missing the point, because that is the whole point of a cheque.
No—I have to say that I have not noticed any direct impact, at all. The only issue that we may have in the future is that the Financial Services Authority—or whatever the new governing body is—might put restrictions on the shares of market sectors. Both the nationalised banks have large exposure to the property sector and, in Scotland, that may become an issue. I have certainly not noticed anything that would have an impact on international trade.
They have been hit no more than have our operations elsewhere. The Scandinavian banks, which tend to be the major owners of the Estonian banks, have the same issues that every other European and, probably, global bank has, in that lending criteria and margins have changed. There is nothing that is peculiar to the Baltic market.
Thank you.
I apologise for the slight delay. We have been having technical problems with the broadcasting system. I hope that everyone has a functioning mike. The mikes will come on automatically, but it would be helpful if you would check that the red light is on before you start speaking, so that we can ensure that your words are properly recorded for posterity.
We have discussed Scotland House. You talk about hot desking and not taking the bricks-and-mortar approach. In the likes of Estonia, which is a small country, having one contact person might well be sufficient. However, countries such as Germany or China are much larger. I will use Germany as the main example. Would you prefer to have one contact person allocated to each region in Germany, as opposed to trying to have one person cover the whole country, which would be extremely difficult?
That idea is good. I do not suggest that the committee should recommend ripping up everything that we have done when a network exists. I am considering how we can add value.
My final question is also about Scotland House. I firmly believe that Scotland will become an independent nation. Is the idea that Scotland House would not just be used for trade missions but could provide other ways of helping to promote Scotland elsewhere a benefit of bricks and mortar?
Yes—it applies there. Reid Kerr College was ahead of the game in that regard; it was out in the Baltic states with us very early on. It is fair to say that Sandy, who co-ordinated that for Reid Kerr College, mopped up all the opportunities to the exclusion of others. Motherwell College also came out there and, although I cannot remember their names, I am sure that a college from Dundee and a college from the Aberdeen area also came out.
That concludes our questions. Thank you very much for coming along and for your very helpful contribution to our inquiry. We will take a short break while we change panels.
I am the commercial manager at the INEOS petrochemical plant at Grangemouth. Our sister company, the refining company, is also at Grangemouth. We make a large amount of base chemicals, as well as refining and transporting products out of Grangemouth. It is a global market.
I am from NovaBiotics, which is a clinical stage drug discovery and development biotechnology company that is based in Aberdeen.
Thank you for those opening remarks. We had some discussion earlier about the role of Scottish Development International and other agencies in undertaking trade missions and whether trade missions should be sector specific or more general. Do you have any views on that? You should feel free to answer any of our questions but you are not obliged to answer every question.
I have been on both multisector and single-sector trade missions and, unlike John McGlynn, I found them both very good. In the life sciences, we are perhaps less competitive with each other because we are all working in different sectors within the life sciences. I would not differentiate between the two types of mission.
Sector-specific trade missions are important for the life sciences. In the Scottish company base, we do not really compete among ourselves. John McGlynn mentioned how other people can help a business through their contacts. Being in an area among focused individuals who come to see us—for example, from the Indian biotechnology sector and Indian pharma-companies—is vital to our success. I have been on a number of well-attended trade missions. If they were made multisectoral, they could become too large and we would not get to meet everybody.
We heard evidence from previous witnesses that representatives of Scotland in the business club Scotland initiative and global Scots are important contact points and, indeed, potential organisations without any costs. Do any of your companies have a view of how you would play into the network to promote Scottish business abroad?
Absolutely. We have had good experience with members of the globalscot network coming to Scotland and taking back what we have. Particularly in the life science sector, there are a lot of fantastic global Scots in industry all over the world. It is good to have a chance to have them come and see four, five or six companies in a couple of days and take what we have here back with them. From that, we have made some fantastic contacts and made potential links into very big pharmaceutical companies.
I went on a mission to China a couple of years ago and visited the international peace hospital. I was surprised to meet a global Scot—a Dr Cheng—who had been trained in Edinburgh. She was very helpful. It was excellent.
Absolutely. My own experience is of the University of Aberdeen, but other universities send annual academic missions to India and other key areas. With links through the Scottish universities life sciences alliance—SULSA—across Scotland, the universities are really punching above their weight, promoting the recognised academic excellence, and taking it out there internationally.
From the chemical sector’s perspective, the coming together of the different university departments in Scotland under the heading of Scotchem has made a huge difference—there is a lot of excellence in Scotland. The universities have a degree of presence when they operate as Scotchem compared with when they operate as individual university chemistry departments. It is important for them to get recognition.
Again, I have an example from experience this year. The person who heads up the SDI office in California is obviously there because of his expertise in life science, and the office’s San Jose base makes sense because of the life science cluster in California. We were not aware, but the office flagged it up, that there were key manufacturers of the compounds that we develop who we should see, and back in January it set up two visits that we would otherwise have missed. It has expertise not just in the sector but in the specific markets that we operate in. It identified some very good links for us.
Having the step between the offices of the high commissioners and ambassadors, who clearly do not have the understanding of the science or the companies, and an agency such as Scottish Development International, with people on the ground who have a background in the area, is essential to moving deals forward.
The committee is trying to identify best practice, wherever it is in the world, to inform our recommendations.
I echo Ken Richardson’s point that, as the pot is not limitless, the question is where the aid that is available is best spent. As we keep saying, we need to think hard about infrastructure. Many people ask how many jobs will be created, but we need to take a step back and think about the number of jobs that might be created if we were to build the infrastructure. In that light, we might well make a different decision.
We are reporting success. RSA has made a difference in places. There is Phoenix Chemicals’s move into the old Annan site, and there have been issues to do with the restructuring of GlaxoSmithKline in Irvine. Both restructurings have been supported by RSA, which has secured those important sites. There are other examples, too.
I have a final comment to Gordon Hay. It was refreshing to find that his written submission was positive about what is already in the public sector. It is all too common for everyone in Scotland, both in public and private life, continually to knock what is available and to downplay the facilities and services that are in existence. Of course, we are here to look at how things can be improved, but his comments were very helpful.
On the spin-out question, the easy route is to have one centre where several spin-outs can come together geographically. However, wherever there is a cluster it is key that the infrastructure is there for the spin-outs to develop. Last week, we were delighted about the news in Aberdeen that we are to have a second incubator unit, which is great. In every major town or city, where the universities are, where we have already started to attract big pharmaceutical players and where we have support from the clinical services, the NHS and the clinical research organisations, there need to be the mini-clusters that then form part of the Scottish super-cluster. We must make sure there is local infrastructure to support that, which then fans out into a wider countrywide network.
My final question is on the lack of venture funding in Scotland. Is the way in which the public sector uses available funding other than RSA grants, such as the co-investment fund and equity funding, sufficient? If not, could such funding be used more imaginatively to leverage in more venture funding?
I want to ask INEOS and Dow what relationships they have with technical education in the Falkirk and Grangemouth area to help with the supply of a skilled workforce to their establishments there.
The figure for apprentice technicians can be 16 to 20.
Other companies in the industry are in a similar position to Dow. Syngenta has looked at technician recruitment as it has developed its site, whereas the KemFine site has shrunk a little, although it still needs some new people.
That concludes the evidence-taking session. I thank the witnesses for coming along and for their helpful contributions to our inquiry. I am sure that we will take into our final report a number of useful lessons from what they have said.
Previous
Attendance